课题基金 / 基金详情

DEVELOPMENT OF TESTS FOR ACELLULAR PERTUSSIS VACCINES

DEVELOPMENT OF TESTS FOR ACELLULAR PERTUSSIS VACCINES
无细胞百日咳疫苗检测方法的开发
批准号:
3804655
负责人:
D L BURNS
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

D L BURNS的其他基金

相关文献

中文摘要
翻译
因为整个细胞的给药都有副作用 在疫苗方面,开发改良的百日咳疫苗是当务之急。 食品和药物管理局负责确保这些 疫苗既安全又有效。因此,我们开发了一种 测试这些疫苗的安全性和效力的一系列检测方法。这些 化验测试疫苗的纯度,无毒性,缺乏能力 恢复到有毒的形式,并具有免疫原性。特别是,已经做出了努力 建立无细胞百日咳疫苗效价测定方法 可以用来作为重复性的可靠度量 这些疫苗的制造。一种标准化的酶联免疫吸附试验目前正在进行 它将测量小鼠对这四种病毒的免疫反应 在无细胞百日咳疫苗中发现的抗原。这些抗原是 丝状血球蛋白,百日咳类毒素,69 kDa蛋白质,菌毛。 GRANT=Z01BA07020 百日咳实验室负责百日咳的常规控制检测 百日咳疫苗效力和毒性。它的毒性和效力 获得许可的疫苗的百日咳疫苗成分在 产品可以放行。 百日咳实验室的对照试验用于确定 美国许可机构发行的疫苗中的百日咳成分 在约会期间有足够和稳定的效力,并且是自由的 从毒性引起的不良反应。 合计对效力、稳定性和保护单位的满意估计 以小鼠为动物模型,确定人的免疫剂量。在……里面 此外,小鼠被用来通过早期观察来确定疫苗的毒性 以及后期体重变化。 除了对提交的每一种疫苗进行实验室检查外 发布、控制测试涉及检查制造商的协议 令人满意的生产方法和控制试验 制造商。 在本报告所述期间, 提交发布的百日咳疫苗的效力和毒性为 注意到了。 材料允许的情况下,百日咳实验室也进行控制 对国外生产的疫苗进行检测,可供参考 世界卫生组织的检测实验室。
英文摘要
Because of adverse effects associated with the administration of whole cell vaccine, development of improved pertussis vaccines is of high priority. The Food and Drug Administration is responsible for ensuring that these vaccines are both safe and effective. We have therefore developed a battery of assays to test the safety and potency of these vaccines. These assays test the vaccines for purity, lack of toxicity, lack of the ability to revert to a toxic form, and immunogenicity. In particular, efforts have been expended to develop a potency assay for acellular pertussis vaccine which can be used as a reliable measure of the reproducibility of manufacture of these vaccines. A standardized ELISA is currently being developed which will measure the immune response in mice to the four antigens found in acellular pertussis vaccines. These antigens are filamentous hemagglultinin, pertussis toxoid, 69 kDa protein, and fimbriae. GRANT=Z01BA07020 The Laboratory of Pertussis is responsible for routine control testing of pertussis vaccine potency and toxicity. The toxicity and potency of the pertussis vaccine component of licensed vaccines are tested before the product can be released. Control testing in the Laboratory of Pertussis is used to determine that the pertussis component of vaccine issued by U.S. licensed establishments have adequate and stable potency through the dating period and are free from untoward reactivity due to toxicity. Satisfactory estimates of potency, stability and protective units per total human immunizing dose are determined using mice as animal models. In addition, mice are used to determine vaccine toxicity by observing early and late weight changes. In addition to laboratory examination of each vaccine submitted for release, control testing involves reviewing the manufacturer's protocol for satisfactory production methods and control tests performed by the manufacturer. During the period described by this report, no significant changes in potency and toxicity of pertussis vaccines submitted for release were noted. When materials allow, the Laboratory of Pertussis also performs control testing on vaccines from foreign manufacturers and serves as a reference testing laboratory for the World Health Organization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES OF THE STRUCTURE AND FUNCTION OF PERTUSSIS TOXIN
  • 批准号:
    2568888
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L BURNS
  • 依托单位:
    --
MOLECULAR CHAPERONES
  • 批准号:
    3770287
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L BURNS
  • 依托单位:
    --
SEROLOGICAL RESPONSE TO BORDETELLA PERTUSSIS ANTIGENS
  • 批准号:
    3804640
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L BURNS
  • 依托单位:
    --
SEROLOGICAL RESPONSE TO BORDETELLA PERTUSSIS ANTIGENS
  • 批准号:
    3792359
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    D L BURNS
  • 依托单位:
    --